Company: AAM-UN
Filing Date: 2025-03-11
Form Type: 10-K
Source: 0001213900-25-022743
Chunk: 198

Company: AA Mission Acquisition Corp.
Filing Date: 2025-03-11
Form: 10-K
Item: Item 1B
Chunk 198
---
 31, 2024.

Investments
Held in Trust Account

The
Company’s portfolio of investments held in the Trust Account is comprised of investments only in U.S. government securities with
a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which
invest only in direct U.S. government treasury obligations. The Company’s investments held in the Trust Account are classified
as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains
and losses resulting from the change in fair value of investments held in Trust Account are included in dividend earned on marketable
securities held in Trust Account in the accompanying statements of operations. The estimated fair value of investments held in the Trust
Account is determined using available market information. As of December 31, 2024, the Trust Account had balance of $353,339,173. The
dividend earned from the Trust Account totaled $6,614,173 for the period from February 9, 2024 (inception) through December 31, 2024,
which were fully reinvested into the Trust Account as earned and unrealized gain on investments and therefore presented as an adjustment
to the operating activities in the Statements of Cash Flows.

Concentration
of Credit Risk

Financial
instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution,
which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. Any loss incurred or a lack of access
to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows.

Offering
Costs

Offering
costs consist of legal, accounting, and other costs (including underwriting discounts and commissions) incurred through the balance sheet
date that are directly related to the IPO and that were charged to shareholders’ equity upon the completion of the IPO on August
2, 2024.

Warrant
Instruments

The Company accounted for the Public and Private Warrants to be issued
in connection with the IPO and the Private Placement in accordance with the guidance contained in FASB ASC Topic 815, “Derivatives
and Hedging”. Accordingly, the Company evaluated and classified the warrant instrument under equity treatment at their assigned
value.

F-9

Net
Loss Per Ordinary Share

The Company complies